TA214 Breast cancer - bevacizumab (in combination with a taxane): Appendix A provisional matrix of stakeholders
TA214 Breast cancer - bevacizumab (in combination with a taxane): Appendix A provisional matrix of stakeholders
29 July 2013 (97.84 Kb 28 sec) |
This page was last updated: 26 July 2013